Absci Corp. (ABSI)
11.07
+0.32
(+2.98%)
USD |
NASDAQ |
Oct 02, 16:00
11.10
+0.03
(+0.27%)
After-Hours: 20:00
Absci Gross Profit Margin (Quarterly) : -747.8% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -747.8% |
| March 31, 2026 | -1.17K% |
| December 31, 2025 | -335.1% |
| September 30, 2025 | -651.9% |
| June 30, 2025 | -405.9% |
| March 31, 2025 | -160.6% |
| December 31, 2024 | -386.3% |
| September 30, 2024 | -97.24% |
| June 30, 2024 | -166.5% |
| March 31, 2024 | -280.4% |
| December 31, 2023 | -930.8% |
| September 30, 2023 | -372.2% |
| June 30, 2023 | -3.89% |
| Date | Value |
|---|---|
| March 31, 2023 | -176.1% |
| December 31, 2022 | -130.3% |
| September 30, 2022 | -43.69% |
| June 30, 2022 | -213.5% |
| March 31, 2022 | -254.8% |
| December 31, 2021 | -90.01% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | 52.76% |
| Prime Medicine, Inc. | -54.68% |
| Beam Therapeutics, Inc. | -1.00K% |
| Moderna, Inc. | -7.59% |
| Tenax Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.07% |
| Return on Assets | -53.31% |
| Return on Invested Capital | -59.44% |
| Profit Margin (Quarterly) | -10.44K% |
| Operating Margin (Quarterly) | -10.74K% |
| Return on Net Operating Assets | -184.8% |